Home › Upcoming votes › Ocugen, Inc.
This meeting took place on September 21, 2026. Ocugen, Inc. reported the official results on Form 8-K, filed September 23, 2026 (read it on EDGAR); they are listed below.
Read the proxy statement on EDGAR
Ballot read from the proxy statement and checked. As listed in Ocugen, Inc.’s proxy statement, with the board’s recommendation on each item.
| # | Item | Proposed by | Board recommends | Last year (same kind of item) |
|---|---|---|---|---|
| 1 | APPROVAL OF THE ADOPTION OF AN AMENDMENT TO OUR CHARTER TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK BY 250,000,000 SHARES | Board | For | — |
| 2 | APPROVAL OF ADJOURNMENT OF THE SPECIAL MEETING TO SOLICIT ADDITIONAL PROXIES IF THERE ARE INSUFFICIENT VOTES Adjournment |
Board | For | — |
From Ocugen, Inc.’s Form 8-K, filed June 5, 2025, for the meeting held June 5, 2025 (read it on EDGAR). Support is the share of votes cast that were FOR: abstentions and broker non-votes are left out.
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| Elect Director: Uday B. Kompella, Ph.D. | 74% | — |
| Elect Director: Blaise Coleman | 96% | — |
| Elect Director: Satish Chandran, Ph.D. | 96% | — |
| 2. Ratification of Independent Registered Public Accountant | 97% | — |
| 3. Approval, on an advisory basis, of the compensation of the Company's named executive officers | 82% | Approved |
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| 2. Approved by the Company's stockholders at the Special Meeting | 79% | Approved |
The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.